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To examine the association of objectively measured physical activity (PA) intensity
levels and sedentary time with arterial stiffness in women with systemic lupus erythe-
matosus (SLE) with mild disease activity and to analyze whether participants meeting the
international PA guidelines have lower arterial stiffness than those not meeting the PA
guidelines.
Methods
The study comprised 47 women with SLE (average age 41.2 [standard deviation 13.9])
years, with clinical and treatment stability during the 6 months prior to the study. PA intensity
levels and sedentary time were objectively measured with triaxial accelerometry. Arterial
stiffness was assessed through pulse wave velocity, evaluated by Mobil-O-Graph® 24h
pulse wave analysis monitor.
Results
The average time in moderate to vigorous PA in bouts of10 consecutive minutes was
135.1±151.8 minutes per week. There was no association of PA intensity levels and seden-
tary time with arterial stiffness, either in crude analyses or after adjusting for potential
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Conclusions
Our results suggest that PA intensity levels and sedentary time are not associated with arte-
rial stiffness in patients with SLE. Further analyses revealed that patients with SLE meeting
international PA guidelines did not present lower arterial stiffness than those not meeting
the PA guidelines. Future prospective research is needed to better understand the associa-
tion of PA and sedentary time with arterial stiffness in patients with SLE.
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown aetiology that pre-
dominantly affects young adult women. The prognosis of SLE has improved significantly in recent
decades [1] and has led to new comorbidities, such as clinical and subclinical atherosclerotic car-
diovascular diseases (CVD) [2]. In fact, CVD, which are characteristically of early presentation
and accelerated evolution [3], have become the main cause of mortality in this population [3].
Arterial stiffness is a marker of subclinical atherosclerosis that allows the detection of
mechanical changes in the distensibility of the arteries previous to atherosclerosis develop-
ment, and is a powerful predictor of CVD independently of the presence of other cardiovascu-
lar risk factors [4,5]. Arterial stiffness, measured by pulse wave velocity (PWV), is significantly
increased in patients with SLE [6,7] and is associated with the development of CVD [8]. There-
fore, understanding potential modifiable factors that might be associated with lower arterial
stiffness in patients with SLE is of clinical and public health interest.
Physical activity (PA) is defined as any bodily movement produced by skeletal muscles that
results in energy expenditure. PA in daily life can be categorized into occupational, sports,
conditioning, household, or other activities [9]. The term ‘sedentary’ can operationally be
defined as any waking sitting or lying behaviour with low energy expenditure [10]. The term
‘sedentary behaviour’ therefore typically refers to sitting/lying behaviour rather than a simple
absence of moderate-to-vigorous PA (MVPA) [10]. There is enough information about exer-
cise physiology to support the well-documented public health guidelines promoting at least
150 min/week of moderate-vigorous leisure-time PA aimed at decreasing risks for metabolic
diseases [11]. Moreover, current physical activity guidelines, including patients with rheumatic
diseases, recommend a minimum of 150 minutes of MVPA per week accumulated in bouts
lasting at least 10 minutes [12]. In patients with SLE, it has been observed that low PA levels
were associated with increased subclinical atherosclerosis, and more severe organ damage was
associated with less PA of “low to moderate” intensity, compared to general population
[13,14]. In addition, it has been suggested that in adults, long lasting periods of sedentary time
are associated with a worse cardiometabolic risk profile, and greater risk of clinical and sub-
clinical atherosclerosis [15]. Furthermore, in general population, daily sitting time or low non-
exercise activity levels may have a significant direct relationship with each of these medical
concerns: mortality, CVD, type 2 diabetes, metabolic syndrome risk factors and obesity [11]. It
has been evidenced that endothelial function declines with age and sedentary lifestyle, and this
is associated with an increased risk for CVD in general population [16]. Most of previous
research has been conducted in the general population or in patients with CVD. However, no
prior study has examined the extent to which physical activity or sedentary time (objectively
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measured by accelerometry) might be associated with arterial stiffness in patients with SLE.
We hypothesized that lower levels of PA and higher sedentary time would be associated with
higher arterial stiffness in patients with SLE.
Therefore, the present study aimed to examine the association of objectively measured PA
intensity levels and sedentary time with arterial stiffness in patients with SLE and whether par-
ticipants meeting the international PA guidelines present lower arterial stiffness than those not
meeting the PA guidelines.
Materials and methods
Study design and participants
In this cross-sectional study, a total of 144 women with SLE were invited to participate in the
study from the Systemic Autoimmune Diseases Unit of the “Virgen de las Nieves” University
Hospital or the “San Cecilio” University Hospital.
Inclusion criteria were: fulfilling 4 ACR classification criteria [17], at least 1 year of fol-
low-up at the respective autoimmune unit and presenting clinical stability (defined as no
changes in Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and/or the treat-
ment) during the 6 months prior to the beginning of the study. Exclusion criteria were: not
being able to read, understand and/or sign the informed consent, personal history of CVD in
the previous year and having received a biological treatment or the need of prednisone (or
equivalent) higher than 10 mg / day in the past 6 months. Furthermore, in the accelerometry
analysis, a minimum of ten or more hours of registration per day during the seven days of
recording was necessary to be included in the study [18].
The patients signed written informed consent after receiving detailed information about
the study procedures. The study protocol was reviewed and approved by the Research Ethics
Committee of Granada.
Procedures
Each patient received a dossier with detailed information about the study design and evalua-
tion protocols, as well as the objectives and purpose of the study.
The patients were evaluated in October 2016, where sociodemographic data and clinical
history were recorded, anthropometric measures and body composition were assessed, and
PWV was measured. Finally, an accelerometer was given to each participant. They were asked
to wear the accelerometers for the following 9 days, and were instructed on how to fill out the
sleep diary.
Measurements
Sociodemographic variables and clinical history. Age, educational level, occupational sta-
tus, family history of CVD, personal history of cardiovascular risk factors and treatments, and
SLE data (diagnostic criteria, year of diagnosis, time of evolution and treatments) were registered
by questionnaires. The disease activity was measured by the SLEDAI [19]. Accumulated organ
damage was assessed by the Damage Index for Systemic Lupus Erythematosus (SDI) scale [20].
Anthropometric measures and body composition. Weight was measured in kilograms
(InBody R20, Biospace, Seoul, Korea) and height in centimeters using a stadiometer (SECA
222, Hamburg, Germany). Body mass index (BMI; kg/m2) was calculated. Body fat percentage
and muscle mass was measured by Bioelectrical impedance (InBody R20, Biospace, Seoul,
Korea). Waist circumference (at the umbilical level) and hip circumference (at the level of the
iliac crest) were measured by non-elastic anthropometric tape (SECA 200).
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Pulse wave velocity. The Mobil-O-Graph1 24h pulse wave monitor (IEM GmbH, Stol-
berg, Germany), which is based on the oscillometry recorded by a blood pressure cuff placed
on the brachial artery [21], was used to measure PWV. Data obtained by the recorder can be
easily transferred to a computer-based central database by use of a Blue-tooth interface. The
central database is a hypertension management software (IEM GmbH, Stolberg, Germany)
[22]. This device has been largely shown to be valid a reliable for measuring PWV in different
populations [23,24], met the accuracy requirements of the British Hypertension Society (BHS)
[25–27] standard, and can be recommended for clinical use [22].
PA levels and sedentary time. PA was objectively measured by accelerometry [28]. Data
was collected using triaxial accelerometer GT3X+ (Actigraph, Pensacola, Florida, USA), stored
at an epoch length of 60 seconds and with a frequency rate of 30 Hz [29]. Participants wore the
accelerometer on the hip secured with an elastic tape. The device was carried over the whole
day for seven consecutive days except when bathing, swimming or sleeping, because non-sleep
patterns were measured. PA was recorded up to seven days, starting from the day the partici-
pants received the accelerometers until the day that they were instructed to return the device.
It was necessary a minimum of ten or more hours of registration per day during the seven
days of recording to be included in the study [18]. It was considered as non-wearing time and
consequently excluded from the analysis bouts of 90 continuous minutes (30 minutes small
window length and 2 minutes skip tolerance) of 0 activity intensity counts [30]. Furthermore,
values with recording of more than 20000 counts per minute were excluded from the analyses
(potential malfunction). Accelerometer wearing time was calculated by subtracting the non-
wear time and the sleeping time (obtained from the sleep diary where patients wrote time they
went to bed and time they woke up) from the total registered time for each day. Sedentary
time was estimated as the amount of time accumulated below 200 counts per minute (cpm) in
the PA vector magnitude during periods of wear time [31]. PA intensity levels (light, moderate
and vigorous) were calculated based upon recommended PA vector magnitude cut points
[29–31]: 200–2689, 2690–6166 and6167cpm, respectively. All values were expressed in min/
day. Moderate-to-vigorous PA (MVPA) intensity level was obtained through the sum of mod-
erate and vigorous PA. The average time per week of MVPA in bouts of10 minutes (bouted
MVPA) was calculated (up to 2 minutes below the cut point allowance) according to the PA
recommendations for adults [12]. However, recent evidence also supports health benefits with
MVPA performed in bouts shorter than 10 min [32]. It was required the ActiGraph software
(Actilife version 6.11.9) for data download, reduction, cleaning and analyses.
Statistical analysis
Descriptive statistics are provided as mean and standard deviation for quantitative variables
and percentages for categorical variables. Normality of the main variables was checked using
histograms and the Shapiro-Wilk test. The association of PA intensity levels (light PA, moder-
ate PA, MVPA, total PA and bouted MVPA) and sedentary time with arterial stiffness was ana-
lyzed using linear regression models, with PWV as dependent variable and PA levels and
sedentary time as independent variables in separate models. Three adjustment models were
conducted: model 1 was adjusted for accelerometer-wear time; model 2 added BMI, smoking
habit, blood pressure to model 1; model 3 added age to model 2. Further adjusting for SLEDAI
did not change the coefficients. Normality of the residuals was analyzed and was reasonably
met. Differences in PWV of participants meeting vs. not meeting the PA guidelines were
assessed with analysis of covariance (ANCOVA), where PWV was entered as dependent vari-
able, the group (0 = not meeting the guidelines; 1 = meeting the guidelines) was entered as
independent variable, and accelerometer-wear time, BMI, smoking habit, blood pressure and
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age were entered as covariates. All statistical analyses were performed using the Statistical
Package for the Social Sciences, version 23.0 for Windows (SPSS, IBM, Armonk, NY, USA),
and statistical significance was set at P<0.05.
Results
The flowchart of the participants included in this cross-sectional study is presented in Fig 1.
Of the 144 patients initially invited, 81 refused to participate (i.e. 41 patients reported living
too far from the hospital; 36 were unable to find time to perform the evaluations; and 4 were
Fig 1. The flowchart of the selection of the patients with systemic lupus erythematosus with mild disease activity (n = 47).
https://doi.org/10.1371/journal.pone.0196111.g001
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not interested), 12 patients did not present clinical stability during the 6 months prior to the
beginning of the study, and 2 patients had CVD during the previous year. A total of 49 partici-
pants were finally included in the study. However, 2 patients refused wearing the accelerome-
ter during one week. Thus, the final sample size for this study was 47 women with SLE.
The sociodemographic and clinical characteristics of the study participants are presented in
Table 1. The quantitative variables were presented as mean (standard deviation; SD) and the
qualitative variables as frequency and percentage (n, %). Participants were, on average, 41
years old, and 45% of participants reported an educational level of no studies or secondary
school. Study participants presented a SLEDAI of 1.9 (SD 3.7) and a SDI of 0.5 (SD 0.9), and a
total criteria for SLE of 5 (SD 0.8). The majority of participants (96%) were consuming hydro-
xychloroquine. Participants meeting the PA guidelines presented a higher percentage of renal
(57.1%) and hematologic (57.1%) disease than participants not meeting the PA guidelines
(30.3% and 36.4%, respectively), although these differences were not significant.
Table 1. Socio-demographic and clinical characteristics in women with systemic lupus erythematosus (n = 47).
Characteristics Total (n = 47) Meeting PA guidelines (n = 14) Not meeting PA guidelines
(n = 33)
Age (years; mean, SD) 41.2 13.9 46.1 12.2 39.1 14.2
Educational level (n, %)
No education 4 8.2 3 21.4 1 3
Primary and secondary education 19 36.8 6 42.8 13 39.4
Higher education 24 55.1 5 35.7 19 57.6
Duration of SLE (years; mean, SD) 11.7 9.3 15.9 8.2 10.2 9.4
Criteria for SLE (n, % yes)
Erythema 22 46.9 5 35.7 17 51.5
Discoid lupus 3 6.1 1 7.1 2 6.1
Photosensitivity 15 32.2 4 28.6 10 30.3
Oral ulcer 14 30.1 4 28.6 9 27.3
Arthritis 31 63.3 9 64.3 20 60.6
Serositis 15 32.2 4 28.6 10 30.3
Renal 19 40.6 8 57.1 10 30.3
Neurological 4 8.2 1 7.1 3 9.1
Hematological 21 44.8 8 57.1 12 36.4
DNA 43 87.8 11 78.6 30 90.9
ANA 46 98 13 92.9 33 100
Total criteria for SLE (mean, SD) 5 0.8 5.1 0.1 4.9 0.8
SLEDAI (mean, SD) 1.9 3.7 1.6 1.9 0.9 1.7
SDI (mean, SD) 0.5 0.9 0.3 0.5 0.6 1
Corticorteroids consumption (n, % yes) 33 70.2 9 64.3 24 72.7
Cumulative corticorteroids exposure, mg (mean, SD) 2864 2696 3131 3244 2752 2477
Drugs consumption (n, % yes)
Hydroxychloroquine 45 95.9 13 92.9 30 90.9
Immunosuppressants (current) 21 44.8 8 57.1 13 39.4
Immunosuppressants (previous) 20 42.7 7 50 13 39.4
Antihypertensive drugs 15 32.2 5 35.7 10 30.3
Statins 8 16.4 5 35.7 3 9.1
SD: Standard Deviation; PA: Physical Activity; SLE: Systemic Lupus Erythematosus; DNA: Double Native Antibodies; ANA: AntiNuclear Antibodies; SLEDAI: Systemic
Lupus Erythematosus Disease Activity Index; SDI: Damage Index for Systemic Lupus Erythematosus.
https://doi.org/10.1371/journal.pone.0196111.t001
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The PA intensity levels and sedentary time in women with SLE are shown in Table 2. The
average accelerometer-wear time result of the included participants was 928.2 (SD 67.2) min/
day. Participants showed sedentary time and light PA of 451.4 (SD 104.7) and 425.7 (SD 96.5)
min/day, respectively. Furthermore, participants showed MVPA (min/day) and bouted
MVPA (min/week) of 51.1 (SD 31.3) and 135.1 (SD 151.8), respectively. Besides, participants
meeting the PA guidelines performed 221 min/week of bouted MVPA more than participants
not meeting the PA guidelines.
The CVD risk factors in women of the study are presented in Table 3. 28% of participants
reported being current smokers and 16.4% of the study participants had arterial hypertension.
Furthermore, study participants presented a BMI of 26.1 (SD 5.1) kg/m2 and a PWV of 6.2
(SD 1.4) m/s. Participants meeting the PA guidelines presented a lower BMI (24.5 kg/m2) and
body fat (32.9%) than participants not meeting the PA guidelines (26.8 kg/m2 and 38.1%,
respectively). Women meeting the PA guidelines presented a higher proportion of dyslipemia
than those not meeting them (P = 0.026).
The association of PA intensity levels and sedentary time with PWV is shown in Table 4.
There was no association of PA intensity levels and sedentary time with arterial stiffness, either
in model 1 or after controlling for additional potential confounders (i.e. models 2 and 3).
Table 2. Physical activity intensity levels and sedentary time in women with systemic lupus erythematosus (n = 47).
Variables Total (n = 47) Meeting PA guidelines (n = 14) Not meeting PA guidelines (n = 33)
PA and sedentary time (min/day) Mean SD Mean SD Mean SD
Accelerometer-wear time 928.2 67.2 946.7 64.3 920.4 67.8
Sedentary Time 451.4 104.7 392.5 111.8 476.4 92.3
Light PA 425.7 96.5 472.7 106.7 405.8 85.1
Moderate PA 48.5 29.5 75.8 36.7 36.9 16.7
Vigorous PA 2.5 6.9 5.3 11.7 1.3 3
MVPA 51.1 31.3 81.6 35.6 38.2 17.7
Bouted MVPA (min/week) 135.1 151.8 289.9 197.8 69.4 48.1
SD: Standard Deviation; PA: Physical Activity; MVPA: Moderate-to-Vigorous Physical Activity.
https://doi.org/10.1371/journal.pone.0196111.t002
Table 3. Cardiovascular risk factors in women with systemic lupus erythematosus (n = 47).
Variables Total (n = 47) Meeting PA guidelines
(n = 14)
Not meeting PA guidelines
(n = 33)
P
Weight (kg; mean, SD) 66.4 12.7 61.1 6 68.5 14.4 0.071
Body fat (%; mean, SD) 36.5 8.6 32.9 9.4 38.1 8.2 0.066
Waist circumference (cm; mean, SD) 83.6 10.1 80.8 8.8 84.5 11.6 0.284
Hip circumference (cm; mean, SD) 100.9 9.9 97.5 6.8 102.5 10.8 0.118
Waist/Hip ratio (mean, SD) 0.8 0.06 0.8 0.07 0.8 0.06 0.799
BMI (Kg/m2; mean, SD) 26.1 5.1 24.5 3.2 26.8 5.8 0.184
Tobacco consumption (n, % yes) 13 28 3 21.4 10 30.3 0.115
HTA (n, % yes) 8 16.4 2 14.3 6 18.2 0.752
Dyslipemia (n, % yes) 8 16.4 5 35.7 3 9.1 0.026
Diabetes (n, % yes) 1 2 0 0 1 3 0.521
Obesity (n, % yes) 6 12.2 1 7.1 5 15.2 0.463
Pulse wave velocity (m/s; mean, SD) 6.2 1.4 6.5 1.2 6.1 1.5 0.421
SD: Standard Deviation; BMI: Body Mass Index; HTA: Hypertension.
https://doi.org/10.1371/journal.pone.0196111.t003
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There was no bouted MVPA x age interaction on PWV (b = -0.00001; 95% CI: -0.00003 to
0.00001; P = 0.263). Further adjustment for SLEDAI, SDI and DMARD (hydroxychloroquine
and immunosuppressants) did not modify the results and (with the aim to provide parsimoni-
ous models) we did not include these variables in the final model. As a higher proportion of
physically active patients presented dyslipemia, we also included dyslipemia as a covariate but
the results were unaltered.
The comparison of the average PWV between participants meeting and not meeting the PA
guidelines of 150 min/week of bouted MVPA is shown in Fig 2. There were no significant dif-
ferences in PWV between the two groups (b = -0.169; 95% CI: -0.480 to 0.143; P = 0.280).
Table 4. Linear regression models examining the association of physical activity intensity levels and sedentary time with pulse wave velocity in women with systemic
lupus erythematosus (n = 47).
Pulse wave velocity β b (95% CI) P1 P2 P3
Sedentary time 0.034 0.001 (-0.001, 0.002) 0.597 0.367 0.484
Light PA -0.014 -0.001 (-0.002, 0.001) 0.467 0.290 0.776
Moderate PA -0.067 -0.003 (-0.008, 0.001) 0.639 0.757 0.164
MVPA -0.072 -0.003 (-0.008, 0.001) 0.683 0.879 0.132
Total PA -0.036 -0.001 (-0.002, 0.001) 0.597 0.367 0.484
Bouted MVPA -0.051 -0.001 (-0.001, 0.0004) 0.474 0.343 0.291
β: standardized regression coefficient; b: non-standardized regression coefficient; CI: Confidence Interval; PA: Physical Activity; MVPA: Moderate-to-Vigorous Physical
Activity.
β, b: these values correspond to the complete model (model 3).
1Model 1: adjusted by accelerometer-wear time.
2Model 2: model 1 plus body mass index, smoking habit and blood pressure.
3Model 3: model 2 plus age.
https://doi.org/10.1371/journal.pone.0196111.t004
Fig 2. Average PWV (95% confidence interval) in women with SLE meeting and not meeting the PA guidelines.
https://doi.org/10.1371/journal.pone.0196111.g002
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Discussion
The main findings of the present study indicate a lack of association of PA intensity levels and
sedentary time with arterial stiffness in women with SLE. Participants who met the interna-
tional PA guidelines did not show lower PWV than those not meeting them.
Benefits of regular PA for general health are well documented [33]. Parsons et al. showed
that low levels of PA and high levels of sedentary time are associated with higher CVD risk
among older people [34]. Furthermore, Matthews et al. evidenced that time spent in sedentary
behaviours was positively associated with CVD incidence and mortality in general population,
and participation in high levels of MVPA did not fully mitigate health risks associated with
prolonged time watching television [35,36]. Although the sedentary time in our study was sim-
ilar to that found in the general population and in patients with Sjögren’s syndrome (451.4
min/day in average) [34,37], the time spent in PA of our participants differed from those
observed in previous studies.
Several studies have analyzed the amount of MVPA performed by patients with SLE. For
instance, Ahn et al. observed that patients with SLE performed 39.6 (SD 29.9) min/day of
MVPA (measured by accelerometery) [38], while Mahieu et al. observed a total of 38.4 (SD
29.6) min/day of MVPA [39]. These numbers are tentative to think that in the present study,
participants performed greater PA (i.e. 51.1 (SD 31.3) min/day of MVPA). However, these
differences in PA levels might be explained by the use of an older version of accelerometer in
previous studies [38,39], the GT3X ActiGraph instead of GT3X+, and because the vector mag-
nitude from the triaxial accelerometry was computed using a different algorithm on a minute-
by-minute basis to classify activity as MVPA by Ahn et al [38].
There is strong evidence supporting the well-documented public health guidelines promot-
ing at least 150 min/week of moderate-vigorous leisure-time PA aimed at decreasing risks for
metabolic diseases [11]. In addition, Garcı́a-Hermoso et al. found that, in adults, long lasting
periods of sedentary time were associated with a worse cardiometabolic risk profile and greater
risk of clinical and subclinical atherosclerosis [15]. Pedersen and Febbraio confirmed that
physical inactivity probably leads to an altered myokine response, which could provide a
potential mechanism for the association between sedentary behaviour and many chronic dis-
eases [40].
However, it is currently uncertain whether there is a link between the levels of PA, mea-
sured objectively by accelerometry, and subclinical atherosclerosis in women with SLE. Imple-
menting strategies or lifestyle modifications to prevent CVD development is of major interest
in this population. Previous studies have investigated the relationship between PA levels and
sedentary lifestyle, measured by accelerometry, and clinical parameters in other autoimmune
disease populations [37].
In SLE patients, it has been observed that more severe organ damage was associated with
less PA of “low to moderate” intensity, compared to general population [14]. Volkmann et al.
found that low PA levels were associated with increased subclinical atherosclerosis, but this
association did not remain significant after controlling for traditional CVD risk factors [13].
Moreover, unlike our study, subclinical atherosclerosis was assessed by intima media thickness
(IMT) and PA was investigated from self-reports questionnaires (the Medical Outcomes Study
Short Form 36, SF-36, and the MESA Typical Week Physical Activity Survey). In addition, it is
important to note that Kruse and Scheuermann evidenced that endothelial function declines
with age and sedentary lifestyle, which are associated with an increased risk for CVD in general
population [16].
The use of questionnaires to assess PA levels has shown significant differences in the esti-
mation of PA in other populations compared to an objective measure such as accelerometry
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[41]. In SLE patients, accelerometer measures and IPAQ energy expenditure estimates showed
a moderate agreement since individuals tend to underestimate daily walking distance, overesti-
mate energy expenditure and overestimate time spent in MVPA with patient-reported PA
instruments [38]. Despite accelerometers did not capture PA time spent in water activities, a
review of the activity logs showed that this time was very low.
To the best of our knowledge, our study is the first to examine the association of objectively
measured PA levels and sedentary time with PWV in a cohort of women with SLE. Based on
previous literature in the general population [15,34–36], it was hypothesized that PA levels
(inversely) and sedentary time (directly) would be associated with arterial stiffness. However,
contrary to our hypothesis, the results of the study showed lack of association of either PA
intensity levels or sedentary time with arterial stiffness. These negative results could be due to
the fact that daily PA might not be sufficient to produce changes in PWV and it is necessary to
perform supervised exercise training to reduce arterial distensibility in this population.
This study has limitations that might partially explain the unexpected results. The cross-sec-
tional nature of the present study precludes establishment of causality. The participants in our
study showed higher PA levels than those observed in previous studies [38,39]. Different accel-
erometer algorithms and/or cutoff points to determine PA intensity levels could explain these
differences [18]. However, it is also possible that our sample was more physically active than
previous ones, as we required clinical stability during the previous 6 months to be included in
the study, just like the low average of SLEDAI and SDI showed. Furthermore, the women
meeting the PA guidelines were older and presented a higher prevalence of comorbidities
(such as dyslipidemia) than those not meeting the guidelines. This might be due to a higher
degree of motivation to move, or a more intensive and strict cardiovascular recommendations
by their physicians, which might have influenced our results. The relatively small sample size
(n = 47) yielded a power to detect a significant association of MVPA with PWV of ~45%.
Therefore, these results must be understood as preliminary/exploratory until future research
with larger sample sizes confirms or contrasts our findings. Finally, the low levels of vigorous
PA observed in the participants (i.e. 2.5 min/day) did not allow assessing its potential influence
on PWV.
Conclusions
Our results suggest that PA intensity levels and sedentary time are not associated with arterial
stiffness in patients with SLE. Moreover, patients with SLE meeting international PA guide-
lines did not show lower arterial stiffness than those not meeting the PA guidelines. Future
prospective research is needed to better understand the association of PA and sedentary time
with arterial stiffness in patients with SLE.
Future research
Future studies should characterize the association of physical fitness with arterial stiffness in
patients with SLE. Preliminary research from our group suggests that higher cardiorespiratory
fitness could attenuate the age-related arterial stiffness in women with SLE [42]. Clinical trials
should also address the extent to which meeting the minimum amount of aerobic exercise
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Validation: Pablo Morillas-de-Laguno, José A. Vargas-Hitos, Antonio Rosales-Castillo, Luis
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in patients with systemic lupus erythematosus and matched controls. Scand J Rheumatol. 2012; 41
(4):290–7. https://doi.org/10.3109/03009742.2011.624117 PMID: 22651371
15. Garcı́a-Hermoso A, Notario-Pacheco B, Recio-Rodrı́guez JI, Martı́nez-Vizcaı́no V, Rodrigo de Pablo E,
Magdalena Belio JF, et al. Sedentary behaviour patterns and arterial stiffness in a Spanish adult popula-
tion—The EVIDENT trial. Atherosclerosis. 2015; 243(2):516–22. https://doi.org/10.1016/j.
atherosclerosis.2015.10.004 PMID: 26523988
16. Kruse NT, Scheuermann BW. Cardiovascular Responses to Skeletal Muscle Stretching: “Stretching”
the Truth or a New Exercise Paradigm for Cardiovascular Medicine? Sport Med. 2017:1–14.
17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of
systemic lupus erythematosus. Arthritis and rheumatism. 1997; 40(9):1725.
18. Migueles JH, Cadenas-Sánchez C, Ekelund Ulf, Nyström CD, Mora-González J, Löf M, et al. Acceler-
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Morillas-de-Laguno P, et al. Cardiorespiratory fitness and age-related arterial stiffness in women with
systemic lupus erythematosus. Eur J Clin Invest. 2018; 48(3):e12885.
Physical activity and arterial stiffness in systemic lupus erythematosus
PLOS ONE | https://doi.org/10.1371/journal.pone.0196111 April 25, 2018 13 / 13
